A Preliminary Study Comparing Methadone and Buprenorphine in Patients with Chronic Pain and Coexistent Opioid Addiction

被引:68
|
作者
Neumann, Anne M. [1 ]
Blondell, Richard D. [1 ]
Jaanimaegi, Urmo [1 ]
Giambrone, Amanda K. [2 ]
Homish, Gregory G. [3 ]
Lozano, Jacqueline R. [4 ]
Kowalik, Urszula [4 ]
Azadfard, Mohammadreza [1 ]
机构
[1] SUNY Buffalo, Primary Care Res Inst, Dept Family Med, Buffalo, NY 14260 USA
[2] SUNY Buffalo, Dept Biostat, Buffalo, NY 14260 USA
[3] SUNY Buffalo, Dept Community Hlth & Hlth Behav, Buffalo, NY 14260 USA
[4] SUNY Buffalo, Sch Med, Buffalo, NY 14260 USA
关键词
Opioid addiction; chronic pain; buprenorphine; methadone; opioids; CHRONIC NONMALIGNANT PAIN; SUBSTANCE-ABUSE; BACK-PAIN; DEPENDENCE; MAINTENANCE; MANAGEMENT;
D O I
10.1080/10550887.2012.759872
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Patients with opioid addiction who receive prescription opioids for treatment of nonmalignant chronic pain present a therapeutic challenge. Fifty-four participants with chronic pain and opioid addiction were randomized to receive methadone or buprenorphine/naloxone. At the 6-month follow-up examination, 26 (48.1%) participants who remained in the study noted a 12.75% reduction in pain (P = 0.043), and no participants in the methadone group compared to 5 in the buprenorphine group reported illicit opioid use (P = 0.039). Other differences between the two conditions were not found. Long-term, low-dose methadone or buprenorphine/naloxone treatment produced analgesia in participants with chronic pain and opioid addiction.
引用
收藏
页码:68 / 78
页数:11
相关论文
共 50 条
  • [41] Intrapretuvalisuse of Methadone, Buprenorphine and Buprenorphine-Naloxone in Patients Under Opioid Maintenance Treatment: A Cross-Sectional Multicentre Study
    Lugoboni, Fabio
    Zamboni, Lorenzo
    Cibin, Mauro
    Tamburin, Stefano
    Andreoli, L.
    Balestra, V.
    Betti, O.
    Biasin, C.
    Bossi, C.
    Bottazzo, A.
    Bove, A.
    Bressan, R.
    Buson, B.
    Caccamo, E.
    Calderan, V.
    Cancian, S.
    Cantachin, F.
    Cantiero, D.
    Canzian, G.
    Cargnelutti, D.
    Carraro, L.
    Casalboni, D.
    Casari, R.
    Certa, G.
    Civitelli, P.
    Codogno, M.
    Cozzi, T.
    Danieli, D.
    De Cecco, L.
    Rossi, A. Dei
    Dell'Antonio, E.
    Del Zotto, R.
    Faccini, M.
    Fadelli, M.
    Favero, E.
    Fiore, A.
    Fona, B.
    Franceschini, A.
    Gaiga, E.
    Gardiolo, M.
    Gentile, N.
    Gerra, G.
    Ghezzo, N.
    Giacomin, M.
    Giannessi, L.
    Giuli, G.
    Guescini, G.
    Hanife, B.
    Laus, S.
    Mantovani, G.
    EUROPEAN ADDICTION RESEARCH, 2019, 25 (01) : 10 - 19
  • [42] Comparing Reasons for Starting and Stopping Methadone, Buprenorphine, and Naltrexone Treatment Among a Sample of White Individuals With Opioid Use Disorder
    Randall-Kosich, Olivia
    Andraka-Christou, Barbara
    Totaram, Rachel
    Alamo, Jessica
    Nadig, Mayur
    JOURNAL OF ADDICTION MEDICINE, 2020, 14 (04) : E44 - E52
  • [43] Comparison Between Preoperative Methadone and Buprenorphine Use on Postoperative Opioid Requirement A Retrospective Cohort Study
    Komatsu, Ryu
    Nash, Michael
    Peperzak, Katherin A.
    Ziga, Taylor M.
    Dinges, Emily M.
    Delgado, Carlos
    Wu, Jiang
    Terman, Gregory W.
    Dale, Rebecca C.
    CLINICAL JOURNAL OF PAIN, 2022, 38 (05) : 311 - 319
  • [44] Usefulness of the Brief Pain Inventory in Patients with Opioid Addiction Receiving Methadone Maintenance Treatment
    Dennis, Brittany B.
    Roshanov, Pavel S.
    Bawor, Monica
    Paul, James
    Varenbut, Michael
    Daiter, Jeff
    Plater, Carolyn
    Pare, Guillaume
    Marsh, David C.
    Worster, Andrew
    Desai, Dipika
    Thabane, Lehana
    Samaan, Zainab
    PAIN PHYSICIAN, 2016, 19 (01) : E181 - E195
  • [45] Comparing methadone and buprenorphine maintenance with methadone-assisted withdrawal for the treatment of opioid dependence during pregnancy: maternal and neonatal outcomes
    Lund, Ingunn O.
    Fitzsimons, Heather
    Tuten, Michelle
    Chisolm, Margaret S.
    O'Grady, Kevin E.
    Jones, Hendree E.
    SUBSTANCE ABUSE AND REHABILITATION, 2012, 3 : 17 - 25
  • [46] The Marginalization of Chronic Pain Patients on Chronic Opioid Therapy
    Peppin, John F.
    PAIN PHYSICIAN, 2009, 12 (03) : 493 - 498
  • [47] Pomegranate juice ameliorates craving and oxidative stress on patients under medication for opioid addiction treatment with methadone and buprenorphine: A ranzomised controlled trial
    Leventelis, Christonikos
    Makri, Sotiria
    Ververi, Anastasia
    Papageorgiou, Kalliopi
    Tentolouri, Anna
    Mountzouridi, Evangelia
    Tekos, Fotios
    Barmpas, Petros T.
    Tasoulis, Sotiris
    Metsios, George S.
    Kouretas, Demetrios
    Veskoukis, Aristidis S.
    CLINICAL NUTRITION ESPEN, 2025, 66 : 34 - 45
  • [48] A retrospective cohort study of mortality rates in patients with an opioid use disorder treated with implant naltrexone, oral methadone or sublingual buprenorphine
    Kelty, Erin
    Joyce, David
    Hulse, Gary
    AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE, 2019, 45 (03) : 285 - 291
  • [49] Secondary Analysis of Pain Outcomes in a Large Pragmatic Randomized Trial of Buprenorphine/Naloxone Versus Methadone for Opioid Use Disorder
    Shulman, Matisyahu
    Luo, Sean X.
    Campbell, Aimee N. C.
    Scodes, Jennifer
    Pavlicova, Martina
    Broffman, Andi
    Saxon, Andrew J.
    Nunes, Edward, V
    JOURNAL OF ADDICTION MEDICINE, 2020, 14 (05) : E188 - E194
  • [50] Validation of a Brief Opioid Compliance Checklist for Patients With Chronic Pain
    Jamison, Robert N.
    Martel, Marc O.
    Edwards, Robert R.
    Qian, Jing
    Sheehan, Kerry Anne
    Ross, Edgar L.
    JOURNAL OF PAIN, 2014, 15 (11) : 1092 - 1101